T43.1X2
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by monoamine-oxidase-inhibitor (MAOI) antidepressants, classified under ICD-10 code T43.1X2, involves the accidental or intentional ingestion of these medications in quantities that can cause harmful effects. MAOIs are a class of antidepressants used to treat depression, but they have a significant potential for adverse reactions, especially if not properly managed. The code specifically refers to cases of poisoning resulting from intentional self-harm, which includes individuals deliberately overdosing on these medications to inflict harm upon themselves. Recognizing the severity and understanding the issues surrounding MAOI poisoning are crucial for effective medical response and mental health support.
Causes & Symptoms
Clinical Causes: Intentional overdose in an attempt to self-harm or suicide Misuse of MAOI medications due to lack of understanding about dosage and interactions Accidental ingestion, especially in individuals with access to prescribed MAOIs Mental health conditions leading to self-injurious behaviors involving medication misuse
Key Symptoms: Severe headache or hypertension Rapid heartbeat or irregular heart rhythms High fever Agitation or confusion Nausea, vomiting, or diarrhea Muscle rigidity or tremors Difficulty breathing or respiratory distress Convulsions or seizures Altered mental state, including hallucinations or coma Skin flushing or sweating
Diagnostic & Treatment
Diagnosis Path: Diagnosis of MAOI poisoning involves a thorough medical history, including recent medication intake and possible overdose. Clinical evaluation focuses on vital signs and neurological status. Laboratory tests such as blood and urine analysis can identify elevated levels of the medication and its metabolites. Blood pressure monitoring is essential due to the risk of hypertensive crises. In some cases, additional tests like ECGs or imaging may be performed to assess organ function or detect complications. A healthcare provider will also evaluate for symptoms indicative of severe poisoning requiring urgent intervention.
Treatment Protocols: Immediate assessment and stabilization of vital signs Activated charcoal administration if within a suitable timeframe after ingestion to reduce absorption Use of intravenous fluids to maintain hydration and support blood pressure Medications to manage hypertensive crises, such as nitroprusside or labetalol Administration of medications like benzodiazepines to control seizures Monitoring in an intensive care setting for severe cases Supportive therapies including oxygen therapy and cooling measures for hyperthermia Psychological evaluation and psychiatric support once the patient is stabilized
Clinical Advice & FAQs
Billing Guidance
Is T43.1X2 a billable ICD-10 code?
Yes, T43.1X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T43.1X2?
Clinical documentation must specify the nature of Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
